Equity Overview
Price & Market Data
Price: $15.75
Daily Change: -$0.74 / 4.70%
Daily Range: $15.60 - $16.50
Market Cap: $176,111,776
Daily Volume: 18,402
Performance Metrics
1 Week: 3.01%
1 Month: -4.20%
3 Months: 17.19%
6 Months: -7.57%
1 Year: -20.45%
YTD: -19.97%
Company Details
Employees: 10
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. Its lead product includes IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for the treatment of atopic dermatitis and alopecia areata. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.